Skip to content
Screener

Penumbra PEN Financing Cash Flow

Financing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$8.78B-54.9%
Stryker logo
StrykerSYK
-$95M
AngioDynamics logo
AngioDynamicsANGO
$621K-91.3%
Medtronic logo
MedtronicMDT
-$888M+33.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$6.29M-190%
TFX
TeleflexTFX
-$82M-246%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.73B+36.0%
Enterprise value$12.71B+38.7%
P/E74.4×+11.1×
P/S8.8×+1.4×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Penumbra’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:45 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001321732-26-000019
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Payment of employee taxes related to vested stock(1,290)(445)
Payments of finance lease obligations(617)(613)
Other(256)
Net cash (used in) provided by financing activities(1,907)2,708
Effect of foreign exchange rate changes on cash and cash equivalents(39)474
NET INCREASE IN CASH AND CASH EQUIVALENTS54,39251,650
CASH AND CASH EQUIVALENTS—Beginning of period186,897324,404
CASH AND CASH EQUIVALENTS—End of period$241,289$376,054

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Penumbra's financing cash flow?
Penumbra (PEN) reported financing cash flow of -$1.91M in Q1 2026.
How has Penumbra's financing cash flow changed year-over-year?
Penumbra's financing cash flow decreased by 170.4% year-over-year, from $2.71M to -$1.91M.
What is the long-term trend for Penumbra's financing cash flow?
Over 4 years (2021 to 2025), Penumbra's financing cash flow has grown at a 137.4% compound annual growth rate (CAGR), from $836K to $26.53M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Penumbra's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude